This leaflet gives dosage, indications, contraindications, side‑effects, storage and other usage details for Flunarizine Hydrochloride capsules (Xibiling).
Flunarizine Hydrochloride capsules (trade name Xibiling) are indicated for the preventive treatment of typical or atypical migraine and for symptomatic treatment of vertigo caused by vestibular dysfunction. The recommended starting dose is two capsules nightly for patients under 65 and one capsule nightly for patients 65 and older, with a maintenance schedule of five days on, two days off.
The medication may cause drowsiness, weight gain and other adverse reactions; it is contraindicated in patients with a history of depression, Parkinson’s disease or other extrapyramidal disorders. Pregnant and lactating women should avoid use, and caution is advised for elderly patients. Store in a light‑proof sealed container; the product is packaged in aluminum‑plastic blister packs of 20 capsules per strip. This manual is written in Chinese.
| Active ingredient | Flunarizine Hydrochloride |
|---|---|
| Strength | 5 mg per capsule |
| Form | Capsules |
| Excipients | Lactose, corn starch, colloidal silicon dioxide, magnesium stearate, talc, gelatin |
| Storage condition | Light‑proof, sealed |
| Packaging | Aluminum‑plastic blister, 20 capsules per strip |
Store the capsules in a light‑proof sealed container.
Animal tests have not shown any direct or indirect harm, but there is no clinical safety data for pregnant women.